InflaRx (IFRX) Finished Goods (2023 - 2025)
InflaRx's Finished Goods came in at $60,875 for Q2 2025, up 21.4% from $50,139 a year earlier.
Powered by 
Analysis
InflaRx (IFRX) Finished Goods (2023 - 2025) Analysis & Trends
At the end of FY2024, InflaRx's Finished Goods was $60,511, down 83.0% from FY2023.
- Going back by year, Finished Goods was $355,154 in FY2023.
- The Q2 2025 figure represents the highest quarterly Finished Goods since Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | InflaRx | 105.98 Mn | -227.64 Mn | 2.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 63,067.90 |
| Dec 31, 2024 | 58,926.92 |
| Jun 30, 2024 | 49,857.58 |
| Dec 31, 2023 | 365,346.61 |
API Access
InflaRx Finished Goods API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=finished-goods&ticker=IFRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "finished-goods", "ticker": "IFRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=finished-goods&ticker=IFRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();